Education
About Us
Working with TipRanks
Follow Us
USANA Health (USNA)
NYSE:USNA
USNA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$23.10 - $45.86
Previous CloseN/A
Volume19.92K
Average Volume (3M)139.90K
Market Cap
$659.82M
Enterprise Value$508.48M
Total Cash (Recent Filing)$179.61M
Total Debt (Recent Filing)$23.00M
Price to Earnings (P/E)19.7
Beta0.91
Next Earnings
Oct 28, 2025EPS Estimate
0.56Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.74
Shares Outstanding18,623,075
10 Day Avg. Volume115,932
30 Day Avg. Volume139,897
Financial Highlights & Ratios
PEG Ratio-11.78
Price to Book (P/B)1.24
Price to Sales (P/S)0.00
P/FCF Ratio13.43
Enterprise Value/Market Cap0.77
Enterprise Value/Revenue0.15
Enterprise Value/Gross Profit0.72
Enterprise Value/Ebitda1.23
Forecast
1Y Price Target
$34.00Price Target Upside5.95% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
USANA Health News
PremiumCompany Announcements
USANA Health Sciences Reports Strong Q2 Sales GrowthPremiumCompany Announcements
USANA Health Sciences Reports Strong Earnings Amid ChallengesPremiumCompany Announcements
USANA Health Reports 11% Sales Increase in Q2 2025
PremiumCompany Announcements
USANA Health Secures New Credit Agreement with Bank
PremiumCompany Announcements
USANA Health Holds Annual Shareholders MeetingOptions Prices
Currently, No data available
---
Ownership Overview
41.10% Insiders
13.39% Mutual Funds
0.63% Other Institutional Investors
27.07% Public Companies and
Individual Investors
USNA FAQ
What was USANA Health’s price range in the past 12 months?
USANA Health lowest stock price was $23.10 and its highest was $45.86 in the past 12 months.
What is USANA Health’s market cap?
USANA Health’s market cap is $659.82M.
When is USANA Health’s upcoming earnings report date?
USANA Health’s upcoming earnings report date is Oct 28, 2025 which is in 94 days.
How were USANA Health’s earnings last quarter?
USANA Health released its earnings results on Jul 22, 2025. The company reported $0.74 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.2.
Is USANA Health overvalued?
According to Wall Street analysts USANA Health’s price is currently Undervalued.
Does USANA Health pay dividends?
USANA Health does not currently pay dividends.
What is USANA Health’s EPS estimate?
USANA Health’s EPS estimate is 0.56.
How many shares outstanding does USANA Health have?
USANA Health has 18,623,075 shares outstanding.
What happened to USANA Health’s price movement after its last earnings report?
USANA Health reported an EPS of $0.74 in its last earnings report, beating expectations of $0.54. Following the earnings report the stock price went up 12.369%.
Which hedge fund is a major shareholder of USANA Health?
Currently, no hedge funds are holding shares in USNA
USANA Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$34.00 (5.95% Upside)
$34.00 (5.95% Upside)
Blogger Sentiment
Bullish
USNA Sentiment 80%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 22.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $360.1K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-22.91%
12-Months-Change
Fundamentals
Return on Equity
6.54%
Trailing 12-Months
Asset Growth
16.33%
Trailing 12-Months
Company Description
USANA Health
USANA Health Sciences, Inc. (USNA) is a global leader in the field of health and wellness, specializing in the development and manufacturing of high-quality nutritional supplements, personal care, and weight management products. Operating primarily in the direct selling industry, USANA offers its extensive product line through a network of independent distributors in various international markets.
USNA Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected a positive sentiment with strong financial performance, successful strategic initiatives, and promising growth from recent acquisitions. However, there were challenges in the Chinese market and a decline in active customers. Despite these issues, the company is confident in its future outlook.Read More>